NeoRecormon ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	2
18	脊髄小脳変性症（多系統萎縮症を除く。）	1

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2009-011516-37-DK (EUCTR)	29/05/2009	15/05/2009	Double blind, placebo-controlled study to assess the effects of Erythropoietin on clinical disabilit ...	Double blind, placebo-controlled study to assess the effects of Erythropoietin on clinical disabilit ...	Multiple Sclerosis, with primary and secondary progressive courses. MedDRA version: 9.1;Level: LLT;C ...	Trade Name: NeoRecormon INN or Proposed INN: Solu-Medrol Other descriptive name: METHYLPREDNISOLONE SO ...	Danish Multiple Sclerosis Research Centre	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Denmark
2	EUCTR2008-005125-11-GB (EUCTR)	19/12/2008	07/01/2009	A pilot single-centre randomised controlled trial of recombinant human erythropoietin versus placebo ...	A pilot single-centre randomised controlled trial of recombinant human erythropoietin versus placebo ...	Primary progressive multiple sclerosis MedDRA version: 9.1;Level: LLT;Classification code 10063401;T ...	Trade Name: Neorecormon Product Name: Recombinant Human Erythropoietin Product Code: rhEPO INN or Propo ...	Walton Centre for Neurology and Neurosurgery	NULL	Not Recruiting			Female: yes Male: yes			United Kingdom

臨床試験数 : 76 / 薬物数 : 98 - (DrugBank : 31) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 65

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-000040-13-AT (EUCTR)	11/02/2009	27/01/2009	Effects of recombinant human Erythropoietin on circulating and intramuscular endothelial progenitor ...	Effects of recombinant human Erythropoietin on circulating and intramuscular endothelial progenitor ...	Friedreich's ataxia (FRDA) is the most common autosomal recessive neurodegenerativ disease (1:50 000 ...	Trade Name: Neorecormon Product Name: Neorecormon Product Code: EU1/97/031-032 INN or Proposed INN: H-1 ...	Medizinische Universität Innsbruck, Univ.-Klinik für Neurologie	NULL	Not Recruiting			Female: yes Male: yes	7	Phase 2	Austria